Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 9/20 | 0.65 |
| ▸ | RAB9A | P51151 | 8/20 | 0.65 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.65 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6567590 | 0.86 | NPC1 (0.70) | NPC1RAB9AEPHX1EPHX2MEN1 | |
| SCHEMBL15934278 | 0.80 | ALDH1A1 (0.49) | NPC1RAB9AMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL12196154 | 0.79 | NPC1 (1.00) | NPC1RAB9AEPHX1EPHX2MEN1 | |
| SCHEMBL15934219 | 0.79 | PTPN7 (0.48) | NPC1RAB9AMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL2752584 | 0.78 | POLB (0.65) | NPC1RAB9AEPHX1EPHX2MEN1 | |
| SCHEMBL13756244 | 0.78 | EPHX1 (0.86) | NPC1RAB9AEPHX1EPHX2MEN1 | |
| SCHEMBL2751488 | 0.77 | NPC1 (0.97) | NPC1RAB9AEPHX1EPHX2MEN1 | |
| SCHEMBL4352171 | 0.77 | RAB9A (0.79) | NPC1RAB9AEPHX1EPHX2MEN1 | |
| SCHEMBL4359761 | 0.77 | RAB9A (0.73) | NPC1RAB9AEPHX1EPHX2MEN1 | |
| SCHEMBL18735757 | 0.76 | RAB9A (1.00) | NPC1RAB9AEPHX1EPHX2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1402887-A1 | New compounds for the inhibition of undesired cell proliferation and use thereof | Jerini AG (DE) | 2004-03-31 | — | — | EP | claimed |
| EP-1402888-A1 | The use of substituted carbocyclic compounds as rotamases inhibitors | Jerini AG (DE) | 2004-03-31 | — | — | EP | claimed |